Alexander Dahmani, PhD QuiO Technologies

Alexander Dahmani is Co-Founder and CEO of QuiO, a New York-based digital healthcare company. QuiO’s CRx platform offers patients the tools to better manage their treatment regimens, by combining connected therapeutics with analytics and behavioral interventions to improve adherence and outcomes.

Alex started QuiO in 2014 while pursuing a PhD at Columbia University. His vision is to enhance the real-world efficacy of existing medications through technology and behavioral science.

Prior to starting QuiO, Alex worked in biotech and technology commercialization. He holds degrees in immunology, genetics and business.